Literature DB >> 6786316

Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.

S Ben-Efraim, R Ophir, E H Relyveld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786316      PMCID: PMC2010632          DOI: 10.1038/bjc.1981.81

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  20 in total

1.  Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells.

Authors:  J E Bubbers; C S Henney
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes.

Authors:  T Diamantstein; A Ulmer
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

3.  Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes.

Authors:  C R Parish
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

4.  Immunologic approach to cancer.

Authors:  N A Mitchison
Journal:  Transplant Proc       Date:  1970-03       Impact factor: 1.066

5.  Discussion paper: the use of glutaraldehyde fixation for the study of the immune response to syngeneic tumor antigen.

Authors:  P Frost; A Edwards; C Sanderson
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

6.  Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines.

Authors:  P C Powell
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

7.  Attempts to induce antitumour immunity with living attenuated cells.

Authors:  G Csaba
Journal:  Neoplasma       Date:  1967       Impact factor: 2.575

8.  Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells.

Authors:  P Frost; C J Sanderson
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

9.  Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.

Authors:  T Kataoka; F Oh-hashi; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

10.  Selective priming of T cells by chemically altered cell antigens.

Authors:  G Dennert; D F Tucker
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.